| Literature DB >> 35434439 |
Dennis Jgamadze1, Victoria E Johnson1, John A Wolf1,2, D Kacy Cullen1,2, Hongjun Song3,4,5,6, Guo-Li Ming3,4,5,7, Douglas H Smith1, H Isaac Chen1,2,4.
Abstract
Traumatic brain injury (TBI) remains a prominent public health concern despite several decades of attempts to develop therapies for the associated neurological and cognitive deficits. Effective models of this condition are imperative for better defining its pathophysiology and testing therapeutics. Human brain organoids are stem cell-derived neural tissues that recapitulate many of the steps of normal neurodevelopment, resulting in the reproduction of a substantial degree of brain architecture. Organoids are highly relevant to clinical conditions because of their human nature and three-dimensional tissue structure, yet they are easier to manipulate and interrogate experimentally than animals. Thus, they have the potential to serve as a novel platform for studying TBI. In this article, we discuss available in vitro models of TBI, active areas of inquiry on brain organoids, and how these two concepts could be merged.Entities:
Keywords: Brain organoids; Neurodegeneration; Stem cells; Traumatic brain injury
Year: 2020 PMID: 35434439 PMCID: PMC9009274 DOI: 10.1016/j.cobme.2020.05.004
Source DB: PubMed Journal: Curr Opin Biomed Eng ISSN: 2468-4511